They had a very large expense from the whealans deal that was brought forward into this years accounts will be much better next f/year
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025